Plaisier P W, van der Hul R L, den Toom R, Nijs H G, Terpstra O T, Bruining H A
Afd. Heelkunde, Academisch Ziekenhuis Rotterdam-Dijkzigt.
Ned Tijdschr Geneeskd. 1993 Apr 10;137(15):768-71.
Determination of the efficacy of extracorporeal shock wave lithotripsy (ESWL) of gallbladder stones and adjuvant treatment with oral bile acids.
Department of Surgery, University Hospital Dijkzigt, Rotterdam, the Netherlands.
Descriptive clinical research.
In 4 years, 133 patients (34 males and 99 females, mean age 49 years (range 24-81)) underwent 299 ESWL sessions, on an outpatient basis except for the first 16. All patients received adjuvant oral bile acid therapy (7-8 mg/kg body weight urso- and chenodeoxycholic acid, starting one day after ESWL). The number of ESWL sessions was 2.5 (mean; range: 1-7) with 2817 shock waves (75-4000), a session duration of 62 min (35-210). 73.7% of the patients (n = 98) required intravenous analgesic sedation.
At a mean follow-up of 13.8 months (1-45), 27.6% of the patients were free of stones. At 1 year after the first ESWL session, 51.0% of the patients with a solitary stone and 8.3% of the patients with 2-10 stones were free of stones (p < 0.0001). Of the 43 patients who had become free of stones 6 developed recurrent stones (14.0%). Fifty-seven patients (42.9%) suffered from colic, 9 (6.8%) from obstruction of the common bile duct, including 4 who developed pancreatitis. Two patients had transient haematuria and one acute cholecystitis; 15 (11.3%) suffered from an oral bile acid-related diarrhoea, which could easily be resolved by lowering the dose of chenodeoxycholic acid. 30 patients (22.6%) underwent cholecystectomy.
Our results reconfirm that ESWL is safe and moderately effective in selected patients. Nowadays most patients choose laparoscopic cholecystectomy, which implies that ESWL will be confined to patients with an increased operative risk and to those who refuse surgery. ESWL should be limited to patients with solitary stones.
确定体外冲击波碎石术(ESWL)治疗胆囊结石的疗效及口服胆汁酸辅助治疗的效果。
荷兰鹿特丹市迪克斯希特大学医院外科。
描述性临床研究。
4年间,133例患者(男性34例,女性99例,平均年龄49岁(范围24 - 81岁))接受了299次ESWL治疗,除最初16例患者外均为门诊治疗。所有患者均接受口服胆汁酸辅助治疗(熊去氧胆酸和鹅去氧胆酸7 - 8mg/kg体重,ESWL治疗后一天开始)。ESWL治疗次数为2.5次(平均;范围:1 - 7次),共发射2817次冲击波(75 - 4000次),每次治疗持续62分钟(35 - 210分钟)。73.7%的患者(n = 98)需要静脉镇痛镇静。
平均随访13.8个月(1 - 45个月),27.6%的患者结石消失。首次ESWL治疗后1年,单发结石患者中51.0%结石消失,2 - 10枚结石患者中8.3%结石消失(p < 0.0001)。在结石消失的43例患者中,6例复发结石(14.0%)。57例患者(42.9%)出现绞痛,9例(6.8%)出现胆总管梗阻,其中4例并发胰腺炎。2例患者出现短暂血尿,1例发生急性胆囊炎;15例(11.3%)出现与口服胆汁酸相关的腹泻,通过降低鹅去氧胆酸剂量可轻易缓解。30例患者(22.6%)接受了胆囊切除术。
我们的结果再次证实,ESWL对部分患者安全且有一定疗效。如今大多数患者选择腹腔镜胆囊切除术,这意味着ESWL将局限于手术风险增加的患者以及拒绝手术的患者。ESWL应仅限于单发结石患者。